Sage Therapeutics, Inc. Patent Application Trends in 2025

Sage Therapeutics, Inc. patent applications in 2025

Top 10 Technology Areas

• C07J43/003 (Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton)
  • Count: 16 patents
  • Example: 20240101592. COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS (Sage Therapeutics, Inc.)
• A61K31/58 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 10 patents
  • Example: 20240122945. USE OF NEUROACTIVE STEROIDS FOR TREATMENT OF SEXUAL DYSFUNCTION (Sage Therapeutics, Inc.)
• C07J9/00 (STEROIDS (seco-steroids)
  • Count: 9 patents
  • Example: 20240287125. NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF (Sage Therapeutics, Inc.)
• A61K31/575 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 5 patents
  • Example: 20240252514. NEUROACTIVE STEROID FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH PARKINSON'S DISEASE (SAGE THERAPEUTICS, INC.)
• C07J41/0094 (Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring)
  • Count: 5 patents
  • Example: 20240309042. NEUROACTIVE STEROIDS AND THEIR METHODS OF USE (SAGE THERAPEUTICS, INC.)
• C07J7/002 (Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms ()
  • Count: 5 patents
  • Example: 20240376144. NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS (Sage Therapeutics, Inc.)
• C07J9/005 (STEROIDS (seco-steroids)
  • Count: 4 patents
  • Example: 20240287125. NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF (Sage Therapeutics, Inc.)
• C07J31/006 (STEROIDS (seco-steroids)
  • Count: 4 patents
  • Example: 20240300995. C7 SUBSTITUTED OXYSTEROLS AND METHODS OF USE THEREOF (Sage Therapeutics, Inc.)
• A61P25/24 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
  • Count: 4 patents
  • Example: 20240245711. A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (Sage Therapeutics, Inc.)
• C07J17/00 (Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide)
  • Count: 4 patents
  • Example: 20240270784. OXYSTEROLS AND METHODS OF USE THEREOF (Sage Therapeutics, Inc.)

Emerging Technology Areas

• C07J73/003 (Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms)
  • Count: 1 patents
  • Example: 20240150393. COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS (Sage Therapeutics, Inc.)
• A61K49/0004 ({Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions})
  • Count: 1 patents
  • Example: 20240216396. NEUROACTIVE STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION IN A LACTATING FEMALE (Sage Therapeutics, Inc.)
• A61K9/0053 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations)
  • Count: 1 patents
  • Example: 20240216396. NEUROACTIVE STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION IN A LACTATING FEMALE (Sage Therapeutics, Inc.)
• A61K9/28 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240238314. TREATMENT OF ESSENTIAL TREMOR (Sage Therapeutics, Inc.)
• A61P23/00 (Anaesthetics)
  • Count: 1 patents
  • Example: 20240132535. OXYSTEROLS AND METHODS OF USE THEREOF (Sage Therapeutics, Inc.)
• A61P3/00 (Drugs for disorders of the metabolism (of the blood or the extracellular fluid)
  • Count: 1 patents
  • Example: 20240132535. OXYSTEROLS AND METHODS OF USE THEREOF (Sage Therapeutics, Inc.)
• C07J63/002 (STEROIDS (seco-steroids)
  • Count: 1 patents
  • Example: 20240368214. POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF (SAGE THERAPEUTICS, INC.)
• C07J71/001 (Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring (spiro-condensed heterocyclic rings)
  • Count: 1 patents
  • Example: 20240368213. COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS (Sage Therapeutics, Inc.)
• C07J51/00 (Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups)
  • Count: 1 patents
  • Example: 20240368213. COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS (Sage Therapeutics, Inc.)
• C07J41/0066 (Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring)
  • Count: 1 patents
  • Example: 20240368213. COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS (Sage Therapeutics, Inc.)

Top Inventors

• Francesco G. Salituro of Marlborough MA (US) (18 patents)
• Albert Jean Robichaud of Boston MA (US) (13 patents)
• Gabriel Martinez Botella of Wayland MA (US) (11 patents)
• Boyd L. Harrison of Princeton Junction NJ (US) (11 patents)
• Maria Jesus Blanco-Pillado of Arlington MA (US) (8 patents)
• Marshall Lee Morningstar of Framingham MA (US) (4 patents)
• Robert Alfonso Lasser of Brookline MA (US) (3 patents)
• James Doherty of Bedford MA (US) (3 patents)
• Jeffrey Martin Jonas of Vero Beach FL (US) (3 patents)
• Handan Gunduz-Bruce of Lexington MA (US) (3 patents)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors